ENTITY
Laurus Labs

Laurus Labs (LAURUS IN)

86
Analysis
Health Care • India
Laurus Labs is a research-driven, integrated pharmaceutical and biotechnology company specializing in Active Pharmaceutical Ingredients (APIs), generic formulations, and Contract Development and Manufacturing Organization (CDMO) services. The company is a global leader in antiretroviral (ARV) APIs and has diversified into oncology, cardiovascular, and biotechnology segments. Laurus Labs is headquartered in Hyderabad, India, and was founded in 2005.
more
bullish•Smartkarma
•24 Dec 2016 12:21

Smartkarma - ECM Coverage Weekly Update (26 Dec 2016)

Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs.Accuracy Rate:Our accuracy...

Share
bearish•Laurus Labs
•07 Dec 2016 15:09

Laurus Labs IPO - Fluctuating Margins and Inconsistent Growth Muddle past Record

Laurus labs aims to raise up to US$200m through a mix of primary and secondary issuance of shares.Our fellow insight provider Kemp Dolliver, CFA...

Logo
324 Views
Share
bearish•Laurus Labs
•05 Dec 2016 03:49

Laurus Labs: Final Thoughts

The company has announced a price range of Rs 426 - 428 per share for its listing with bidding set to open on 6 December and closing on 8 December...

Share
bullish•Laurus Labs
•25 Nov 2016 04:24

Laurus Labs IPO Overview

India-based Laurus Labs has filed for a listing on the BSE and NSE, and reportedly plans to raise up to Rs300 crore for debt repayment and general...

Share
x